Influence of Supplementary Vitamin D on Bone Mineral Density When Used in Combination with Selective Estrogen Receptor Modulators
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Vitamin D is regarded as one of the major nutrients that significantly influence bone metabolism. This study aims to look at the effect of supplementary vitamin D on bone mineral density (BMD) in female osteoporosis patients. Methods: The retrospective hospital record review was performed on 282 patients who were diagnosed with osteoporosis and treated with selective estrogen receptor modulators (SERMs) between January 2015 and December 2016. Of these patients, 151 were treated with SERMs only while 131 were treated using both SERMs and vitamin D supplements. The BMD and any occurrence of osteoporotic fracture episode were investigated after one year. The result of two groups was compared to find the significance of vitamin D. Results: Overall, improvement in BMD score was observed in 76% of the patients. The BMD of the SERMs only group improved by 3% in spine and 1% in the hip while that of the SERMs with vitamin D group improved by 6% and 1% respectively. Statistical significance was noticed in the spine only. One distal radius fracture and one single level vertebral fracture occurred in patients of SERMs group while two distal radius fractures occurred in SERMs with vitamin D group. There was no occurrence of around hip fracture in both groups. Conclusions: The result of the current study suggests that additional vitamin D may have some additive effect on improving BMD of the spine. Further study with the larger study population and the extended study period is recommended.
Abstract
Objectives: Vitamin D is regarded as one of the major nutrients that significantly influence bone metabolism. This study aims to look at the effect of supplementary vitamin D on bone mineral density (BMD) in female osteoporosis patients. Methods: The retrospective hospital record review was performed on 282 patients who were diagnosed with osteoporosis and treated with selective estrogen receptor modulators (SERMs) between January 2015 and December 2016. Of these patients, 151 were treated with SERMs only while 131 were treated using both SERMs and vitamin D supplements. The BMD and any occurrence of osteoporotic fracture episode were investigated after one year. The result of two groups was compared to find the significance of vitamin D. Results: Overall, improvement in BMD score was observed in 76% of the patients. The BMD of the SERMs only group improved by 3% in spine and 1% in the hip while that of the SERMs with vitamin D group improved by 6% and 1% respectively. Statistical significance was noticed in the spine only. One distal radius fracture and one single level vertebral fracture occurred in patients of SERMs group while two distal radius fractures occurred in SERMs with vitamin D group. There was no occurrence of around hip fracture in both groups. Conclusions: The result of the current study suggests that additional vitamin D may have some additive effect on improving BMD of the spine. Further study with the larger study population and the extended study period is recommended.
참고문헌 (29)
- "NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy, March 7-29, 2000: highlights of the conference", South Med J, 94, pp.569~573 (2001)
- Astrand J, "3-year follow-up of 215 fracture patients from a prospective and consecutive osteoporosis screening program", Fracture patients care! Acta Orthop, 79, pp.404~409 (2008)
- 엄미정, "Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women", 대한폐경학회지, 23(1), pp.56~62 (2017), 대한폐경학회
- "Fracture Risk Assessment Tool (FRAX®)"[URL]
- Schneider EL, "The aging of America. Impact on health care costs", JAMA, 263, pp.2335~2340 (1990)
- Chrischilles E, "Costs and health effects of osteoporotic fractures", Bone, 15, pp.377~386 (1994)
- Chappard D, "New laboratory tools in the assessment of bone quality", Osteoporos Int, 22, pp.2225~2240 (2011)
- Sunyecz JA, "The use of calcium and vitamin D in the management of osteoporosis", Ther Clin Risk Manag, 4, pp.827~836 (2008)
- 김태희, "Expression of Vitamin D Receptor in Seminal Vesicles of Cholesterol Formula Mice", 대한폐경학회지, 21(2), pp.89~92 (2015), 대한폐경학회
- Oh J, "1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus", Circulation, 120, pp.687~698 (2009)
- Lukert B, "Menopausal bone loss is partially regulated by dietary intake of vitamin D", Calcif Tissue Int, 51, pp.173~179 (1992)
- Villareal DT, "Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass", J Clin Endocrinol Metab, 72, pp.628~634 (1991)
- Adami S, "Vitamin D status and response to treatment in postmenopausal osteoporosis", Osteoporos Int, 20, pp.239~244 (2009)
- Sadat-Ali M, "Influence of vitamin D levels on bone mineral density and osteoporosis", Ann Saudi Med, 31, pp.602~608 (2011)
- Park JH, "Vitamin D status in South Korean population: seven-year trend from the KNHANES", Medicine (Baltimore), 97, pp.e11032~ (2018)
- Tuppurainen MT, "Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?", Osteoporos Int, 8, pp.32~38 (1998)
- Dawson-Hughes B, "Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D", Am J Clin Nutr, 61, pp.1140~1145 (1995)
- Dawson-Hughes B, "Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women", Ann Intern Med, 115, pp.505~512 (1991)
- Islam MZ, "Effect of vitamin D, calcium and multiple micronutrient supplementation on vitamin D and bone status in Bangladeshi premenopausal garment factory workers with hypovitaminosis D: a double-blinded, randomised, placebo-controlled 1-year intervention", Br J Nutr, 104, pp.241~247 (2010)
- Reid IR, "Effects of vitamin D supplements on bone mineral density : a systematic review and meta-analysis", Lancet, 383, pp.146~155 (2014)
- Young Hwa Cho, "Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density", 대한폐경학회지, 22(3), pp.174~179 (2016), 대한폐경학회
- Clemett D, "Raloxifene : a review of its use in postmenopausal osteoporosis", Drugs, 60, pp.379~411 (2000)
- Díez JL, "Skeletal effects of selective oestrogen receptor modulators(SERMs)", Hum Reprod Update, 6, pp.255~258 (2000)
- Sato Y, "Selective estrogen receptor modulators and the vitamin D analogue eldecalcitol block bone loss in male osteoporosis", Biochem Biophys Res Commun, 482, pp.1430~1436 (2017)
- 신창진, "Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single", Korean Journal of Neurotrauma, 12(2), pp.123~127 (2016), 대한신경손상학회[DOI]
- Kanis JA, "Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis : a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial", Bone, 33, pp.293~300 (2003)
- Bjarnason NH, "Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis", Osteoporos Int, 12, pp.922~930 (2001)
- Morii H, "Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis : results from a randomized placebocontrolled trial", Osteoporos Int, 14, pp.793~800 (2003)
- Dane C, "Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis", Gynecol Endocrinol, 23, pp.398~403 (2007)